VRX : Analysis & Opinions

  1. Valeant Gets Default Notice, Senior VP Resigns (VRX)

    May 23, 2016
    The filing delays are related to federal regulators investigating Valeant's accounting practices linked to its dealings with ...
  2. Valeant Falls After Questionable Bonus Payments (VRX)

    May 20, 2016
    Wells Fargo senior analyst David Maris has taken issue with what appears to be a brash statement by the embattled drug company.
  3. Valeant Stock Rises on Possible Asset Sale (VRX)

    May 18, 2016
    Whether these maneuvers will have any material effect on the company is not clear.
  4. Is the Hedge Fund Industry Peaking?

    May 14, 2016
    Learn if the hedge fund industry has crested, and explore the characteristics of the fund community that may have implications ...
  5. Valeant Stock Declines on Hospitals' Price Claims (VRX)

    May 13, 2016
    Shares of Valeant declined almost 11% Thursday after several hospitals complained they had not received promised drug discounts.
  6. Valeant Stock Plummets on Jim Chanos' Short Bet (VRX)

    May 9, 2016
    Famed short seller Jim Chanos last week fanned the flames of doubt about Valeant's future.
  7. 3 Catalysts That Will Drive AERI Higher in 2016 (AERI, VRX)

    May 8, 2016
    Read about the key drivers of Aerie Pharmaceuticals' stock price, which has been volatile since the company's IPO.
  8. 3 Mutual Funds that Profit From a Healthy M&A Market (ARBNX, ...

    May 3, 2016
    Find out which mutual funds to use to profit during a healthy mergers and acquisitions (M&A) market and generate steady returns ...
  9. 6 Reasons to Watch Kythera Biopharm Inc. (AGN, PFE)

    May 1, 2016
    Discover why the Russell 2000 and other investment indexes believe California-based Kythera Biopharmaceuticals Inc. is a ...
  10. Valeant Files Late Annual Report, Restates Results (VRX)

    April 29, 2016
    Valeant Pharmaceuticals filed its overdue 10-K form with the SEC Friday, restating revenues and profits for 2014 and much ...
  11. JANBX: Overview of Janus Balanced Fund

    April 27, 2016
    Discover a balanced mutual fund with a solid performance history, weathering down markets and routinely outperforming equity ...
  12. Valeant Announces New CEO (VRX)

    April 25, 2016
    The embattled Canadian drug maker announced that Joseph Papa, former CEO of Perrigo Co., would be its CEO this morning.
  13. (VRX) Who are Valeant's Main Competitors?

    April 23, 2016
    Learn which companies Valeant is likely watching closely, since it is known for acquiring companies for their products rather ...
  14. Top 3 Companies Owned by Valeant (VRX)

    April 23, 2016
    Learn more about Valeant Pharmaceuticals International Inc. and three of the top companies that Valeant owns or operates ...
  15. Valeant News: Michael Pearson's Return, Sort of

    April 18, 2016
    Explore the circumstances surrounding Michael Pearson’s leave of absence from Valeant, as well as the details of his short-lived ...
  16. Valeant vs. Abbott Labs: Which Is Better for My Portfolio? (VRX, ...

    April 16, 2016
    Explore the differences between Abbott Laboratories and Valeant Pharmaceuticals, as well as which stock is the best addition ...
  17. Deconstructing Two Notorious Story Stocks (VRX, CMG)

    April 8, 2016
    Valeant and Chipotle are once-respected brands that have been undermined by scandals, but traders aren't complaining.
  18. Bill Ackman's Greatest Hits and Misses

    March 22, 2016
    With the recent Valeant fiasco, we take a look back at the best and worst of the gray haired hedge fund manager.
  19. Valeant CEO Steps Down (VRX)

    March 21, 2016
    The markets started on a lower note this morning as equity and commodity prices took a breather from recent rallies.
  20. FedEx Soars, Ackman Sells Mondelez (FDX, MDLZ)

    March 17, 2016
    Shares for FedEx (FDX) rose to their highest level in nearly three months after the logistics giant reported results that ...
  21. How Low Will Valeant Go? (VRX)

    March 16, 2016
    A week after its stock price surged, Valeant Pharmaceuticals International Inc. is down in the dumps once again.
  22. Markets Cautious Ahead of Tomorrow's Fed Meeting (VRX, DSW)

    March 15, 2016
    Declining oil prices and the Federal Reserve meeting are on the market's mind this morning.
  23. 4 Reasons Behind Bill Ackman's Purchase of Zoetis Stock (ZTS, ...

    March 15, 2016
    Find out the reasons behind activist hedge fund manager Bill Ackman's 10% stake in Zoetis, Inc., and learn his plans for ...
  24. Why Valeant Pharmaceuticals Surged 13% Last Week (VRX)

    March 14, 2016
    While VRX shares may look attractive today, take Person's "There is no other big shoe to drop" remark at your own peril.
  25. Bill Ackman's Success Story: Net Worth, Education & Top Quotes ...

    March 7, 2016
    Read about William Ackman, Pershing Square Capital Management's confident and brash portfolio manager and famous activist ...
  26. Canadian Authorities Could Be Looking Into Valeant

    March 1, 2016
    Regulators' involvement with Valeant Pharmaceuticals Intl Inc (NYSE: VRX) could last quite a while, according to John Gavin ...
  27. Top 5 Positions in John Paulson's Portfolio (AGN, VRX)

    February 29, 2016
    Find out which stocks are holding the top five positions in investment guru John Paulson's hedge fund portfolio and which ...
  28. 3 Volatile U.S. Industries to Exploit in 2016 (VRX, IBB)

    February 13, 2016
    Read about volatile sectors in the stock market that may provide opportunities for investors in 2016, including energy, mining ...
  29. Bill Ackman's 2 Best Investments (GGP, CP)

    February 10, 2016
    Learn about the two best investments Ackman ever made. Ackman has demonstrated a consistent track record of success in all ...
  30. Under Pressure: Eyeing Pershing Square's Holdings

    February 2, 2016
    A look at Pershing Square's recent performance, portfolio and future outlook. Should investors follow the money?
  31. Allergan: An Activist Investment Analysis (AGN,VRX)

    January 28, 2016
    Read about the activist investor campaign against Allergan by Bill Ackman. See how Ackman partnered with another drug company ...
  32. The Top 3 Biotechnology Stocks for 2016 (AMGN, VRX)

    December 30, 2015
    Find out more about the top three biotechnology stocks to consider in 2016, and learn about their characteristics and why ...
  33. Valeant Shares up on Walgreens Deal

    December 15, 2015
    Shares of Valeant Pharmaceuticals rose by 15% after it announced a new drug pricing and distribution agreement with Walgreens ...
  34. Congressman Questions VW's "Road of Deceit" (KING, ATV)

    November 3, 2015
    The U.S. EPA​ widened its probe against Volkswagen saying the car maker used the defeat device on other V6 engines to comply ...
  35. 3 Answers For Valeant Investors (VRX)

    October 26, 2015
    Valeant Pharmaceutical Inc., held an investor call to clarify its relationship with specialty pharmaceutical firms. Here ...
  36. Will Valeant's Mea Culpa Save Its Stock?

    October 26, 2015
    This morning, Canadian pharmaceutical maker Valeant Pharmaceuticals International Inc. (VRX) announced a public conference ...
  37. More Volatility Ahead

    September 29, 2015
    Yesterday started the week with a dose of fear as the VIX shot up by almost 17 percent. The index has been consistently trending ...
  38. Citron: 'The Real Problem With Drug Pricing In America Is Forged ...

    September 28, 2015
    Shares of Valeant Pharmaceuticals Intl Inc (NYSE: VRX) were down more than 15 percent on Monday. The decline was triggered ...
  39. Valeant Pharmaceuticals acquires Sprout Pharmaceuticals (VRX)

    August 21, 2015
    On August 20, 2015, Valeant Pharmaceuticals (VRX) announced that they entered into definitive agreement to acquire Sprout ...
  40. Want to Beat the Market? Take on Some Risk

    July 8, 2015
    As we head into a sketchy investment environment, you may want to reverse your thinking to find the best opportunities.
  41. Most Important Mergers And Acquisitions Of 2015

    June 15, 2015
    Nearly halfway through the year, 2015 is proving to be a big one for mergers and acquisitions.
  42. Portfolio Manager Minyi Chen On Why Certain Companies Are Likely ...

    May 18, 2015
    Minyi Chen, portfolio manager of AdvisorShares TrimTabs Float Shrink ETF (NYSE: TTFS) said he believes certain companies ...
  43. Four Breakout Stocks To Watch

    February 19, 2014
    These biotechnology and pharmaceutical stocks continue to put in new highs, but indicators are diverging.
  44. After A Sharp Pullback, Is Allergan Pretty Enough?

    July 31, 2013
    Down on fears about generics and the pipeline, the Street may be underestimating Allergan
  45. Abbott Adds Two Promising Products

    July 15, 2013
    Abbott makes two solid growth acquisitions that should address large markets.
  46. Valeant Eyes Bausch & Lomb

    May 28, 2013
    Canadian pharmaceutical company Valeant has made a name for itself through acquisitions. On May 27 it announced that it was ...
  47. A Good Deal For Actavis, But Warner Chilcott Goes A Little Cheap

    May 21, 2013
    Actavis gets a very useful asset, while Warner Chilcott shareholders get a decent exit.
  48. Adasuve Deal Is Very Good For Alexza, But What About Teva?

    May 9, 2013
    Teva's partnership with Alexza looks like an expensive gamble.
  49. Valeant Works Its Mojo With Medicis

    September 7, 2012
    Valeant makes a bold but logical bid for Medicis.
  50. Valeant Pharmaceuticals Int (USA) and Other Healthcare Stocks ...

    August 15, 2012
    The Nasdaq is trading up 0.2%, the S&P 500 has remained steady and the Dow remains relatively unchanged so far today. ...
  51. Novo Nordisk A/S (ADR) and Other Big Movers In Healthcare

    August 14, 2012
    The Nasdaq has climbed 0.6%, the S&P 500 is up 0.3% and the Dow has risen 0.3%, marking a bad morning for the market. ...
  52. Biggest Healthcare Sector Movers for July 3, 2012

    July 3, 2012
    The market is doing well so far today. The Nasdaq has moved up 0.7%; the S&P 500 is up 0.7%; and the Dow has risen 0.6%. ...
  53. Obagi Puts Its Problems Behind It

    May 25, 2012
    A year ago, Obagi Medical Products faced some problems in Texas that presented an investment opportunity. One year later ...
  54. Stocks To Buy On A Market Sell-Off

    March 8, 2012
    A market pullback will create a buying opportuntiy for some of the top performing stocks.
  55. The Salix Story Keeps Improving

    January 18, 2012
    Salix is a great candidate for growth investors.
  56. Can The Big Gains Continue Into 2012?

    January 3, 2012
    Learn the opportunities and risks that await some top performers in 2012.
  57. 2011 In Review - Pharmaceuticals

    December 29, 2011
    2011 was a surprisingly healthy year for drug stocks.
  58. Canada Is Key For A Strong Portfolio

    November 10, 2011
    With the majority of the developed world still facing problems, Canada is beacon of growth.
  59. Covidien's Image Starting To Change

    August 3, 2011
    Find out why Covidien is much better than many investors assume.
Trading Center